Back

Antithrombotic and anticoagulant treatment following TAVI/TAVR – considerations, recommendations & unmet needs.

26 August 2018 (11:54 - 12:12)
Organised by:
Congress Presentation Part of: Leaflet thrombosis following bioprosthetic valve replacement: storm in a teacup? Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Josep Rodes-Cabau

Quebec Heart and Lung Institute, Quebec (Canada)

4 More presentations in this session

Presentation thumbnail
The pathology of leaflet thrombosis.
Doctor M. Joner (Munich, DE)
Slides Video
Presentation thumbnail
Imaging assessment of leaflet thrombosis and pannus.
Doctor A. Moss (Leicester, GB)
Slides Video
Presentation thumbnail
Clinical Implications of leaflet thrombosis following surgical and transcatheter aortic valve replacement – what are the current data?
Professor H. Eltchaninoff (Rouen, FR)
Slides Video
Presentation thumbnail
Panel discussion.
Video

Access the full session

Session thumbnail
Leaflet thrombosis following bioprosthetic valve replacement: storm in a teacup?

The Event

Event poster

ESC Congress 2018

26 August 2018 11:54 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources